Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2.5 Billion shares down and only 47.5 Billion shares left to sell to fund Kenny and Friends lifestyle. LOL The poor guy is only getting paid $433k to release meaningless PR's ever month or so. PMCB IS A SCAM. IMHO
On April 23, 2021, our Board unanimously approved the Certificate of Amendment (“Charter Amendment”) to our Articles of Incorporation to increase the number of
authorized shares of common stock of the Company from 2,500,000,000 shares to 50,000,000,000 shares, and to make a corresponding change in the number of authorized
shares of capital stock. The Board directed that the Certificate of Amendment be submitted to the stockholders for approval at the Annual Meeting. The form of the text of the
proposed Charter Amendment is set forth on Appendix A to this Proxy Statement (subject to any changes required by applicable law).
Mr. Waggoner’s base salary rate for the fiscal year ended April 30, 2021, was $433,333.
Not that PMCB is even a real Biotech but if they were their old tech is worthless.
Galera Therapeutics Stock Surges After Its Lead Candidate Shows Median OS Of 20 Months In Pancreatic Cancer Study
https://finance.yahoo.com/news/galera-therapeutics-stock-surges-lead-102858519.html
One can not pay attention to anything PMCB related for years and when you check again nothing will have changed. Same old SCAM year after year. Decade after decade. Its all BS the only thing this company does is sell shares and pay its penny stock scamming management. TOTAL SCAM and always has been.
Yawn. PMCB's Three Scammers still collecting $$ and doing NOTHING. Same story no matter what day/week/year it is. LOL PMCB Scamming investors for a Decade and going.....
Lessons are hard to learn in penny land i guess. PMCB is and always has been a SCAM plain and simple. IMHO
But IHub say its -2.07B so someone must have bought all of the outstanding shares plus 2.07 billion shares that don't even exist. LMAO PMCB is a SCAM.
lol Posting years old links to PUMP PR's and a kit Austrianova sells (probably ZERO) on a distributors website is anything but proof this is not a SCAM.
New day new company LMAO.
I always find it funny that some in penny land cannot figure out why a companies PPS doesn't go up everyday yet when they try to buy shares they bid below current PPS. If you believe in a company and you believe it will be worth "BILLION" why are you trying to buy shares at 1/100th of a penny cheaper. BTW PMCB is a SCAM. Always has been always will be because they have NOTHING IMHO.
As usual no proof PMCB is a real Biotech. 7 Years of PR's ZERO releases of clinical or non-clinical data. I suppose Efood and Nuvilex were "Real Companies" also. LMAO 15+ years of "no proof" statements LOL.
LOL there are no shorts and the only ones making money are the flippers. Any long time investor in PMCB is down HUGE. PMCB is a SCAM using a horrible cancer as a means to enrich is scum management.
The only reason for accumulating PMCB at this PPS is if you are already preparing for a tax loss sell for 2021. PMCB the 20+ Years SCAM continues. LMAO
Oh the foolishness of Penny Land. Where a company like PMCB can scam investors for decades. Up goes PPS Down goes PPS and the only ones not affected are the three fools who "Run" PMCB and still cash their checks every Month.
LOL. Penny investors getting an early jump on creating their own tax loss for 2021. Why else anyone would be bidding up this SCAM called PMCB is beyond reasonable thought. PMCB Scamming investors out of their money for 20+ years.
What DD is that? Reading stock market media paid PR's because other then that there is no real information about PMCB. A 3 person "Biotech" with no office where two of the three are a penny stock lawyer and his pal from their last penny stock scam. Then we have a 90 year old former Doctor who hasn't been involved with real research for several decades. Which brings us to the Austrianova clowns who accomplished nothing in 20+ years other then selling their Gimmick technology to a SCAM company so they could use it to sell shares and con investors. PMCB has been a SCAM from day 1. IMHO
People with money don't invest in sub-penny stocks and they don't invest in SCAMS like PMCB>
IND for phase2b in FDA "ON HOLD" file cabinet where it will remain forever.
The only fluid situation with Waggs is what cocktail he is drinking on his never ending vacation. PMCB = SCAM
So close to nothing. Same as always. PMCB is a stock selling SCAM. I business for twenty plus years only to sell HYPE and sell shares.
-0.00065 (-8.23%) is rising?
No Doubt that PMCB will never get to Clinical Trials. 1) The FDA will never approve their IND unless many very expense test and data are provided. 2) PMCB would never spend the money needed because that is Kenny and pals money. 3) PMCB IMO never intended to conduct clinical trials their intention was only to create the appearance of being a real Biotech so they could sell Billions of shares and use those funds only to fund themselves. SCAM Always has been
Must be huge 15 million out of 2.5 BILLION shares traded. PMCB fake rally has begun. LOL
Does PMCB and Ken W have a plan ? Yes. Continue to pretend that PMCB is working on a treatment for Cancer while sucking as much money into their retirement accounts as possible. Same as the last 8+ years of Kenny's leadership. He has made his partners very well paid while shareholders have lost 99% of their $$.
A tough time for who? Not the Management of PMCB the checks keep coming for them. Do you really think they care about shareholders. LMAO
$105,692,395.00 ! This is how much PMCB/Nuvilex/Efood raised and spent mostly on Management pay by selling Hype and Dreams to shareholders while delivering Nothing but an embarrassment of an IND. Wasting the time of FDA regulators who had to review this garbage when they could have been spending time approving a Real Biotech's IND and getting a Real Treatment into clinical trials.
Wait for paid Pumps because that's what PMCB considers news. Waggs has been giving nothing but Hype and the complete failure of the JOKE of an IND PMCB submitted is only more proof that they are nothing but a complete SCAM
Look it up its in the 10q. You would think a PMCB investor would be able to do their own DD.
I think PMCB will issue a PR and then another and another because that is all they do. Its how you run a SCAM. Just keep reporting "progress" but never actually accomplish anything.
Amazing that there are literally over a thousand Biotech's all operating within the FDA guidelines yet only PMCB has been targeted by an FDA/Big Pharma conspiracy. LMAO Its not that PMCB is basically a shell company in business only to Hype and sell shares so that a Penny stock lawyer and his co-scumbags can scam naive investors out of their hard earned money with the dreams of riches that have 0% chance.
Sure it will on April 15th 2055.
Reality half a penny. LOL
LOL PMCB has always been a scam. So was Nuvilex and so was efood safety. There is no proof because the only way to prove it is to file a suit and why would anyone. PMCB has nothing to pay out. That is the beauty of running these penny stock scams is they have nothing to be sued for.
LMAO No one is shorting a half penny stock in OTC land.
LOL. Like the Weekly world News. CIAB used by aliens to create a new species.
PMCB is a 20+ year old scam that hopefully will be gone ASAP.
We only get one shot! LOL unless you have to provide all of the below because you know a penny stock fraud lawyer pretending to run a Biotech will tell you anything that keeps his paychecks coming.
· Provide additional sequencing data and genetic stability studies;
· Conduct a stability study on the final formulated drug product as well as the cells from the Master Cell Bank;
· Evaluate the compatibility of the delivery devices (i.e., the prefilled syringe and microcatheter) with the drug product;
· Provide additional detailed description of the manufacturing process;
· Provide additional product release specifications for the encapsulated cells;
· Demonstrate comparability between the 1st and 2nd generation products and ensure adequate and consistent product performance and safety between the two generations;
· Conduct a biocompatibility assessment using the final finished capsules after the entire drug product manufacturing process (but without cells);
· Address insufficiencies in Chemistry, Manufacturing and Controls information in the cross-referenced Drug Master File;
· Conduct an additional nonclinical study to assess the safety, activity and distribution of the drug product;
· Revise the Investigators Brochure to include any additional preclinical studies conducted in response to the clinical hold and remove any statements not supported by the data; and
· Provide data from a new pig study.
The FDA also requested that we address several issues not related to the clinical hold in an amendment to the IND, including:
· Provide a Certificate of Analysis for pc3/2B1 plasmid that includes tests for assessing purity, safety, and potency;
· Perform qualification studies for the drug substance filling step to ensure that the product remains sterile and stable during the filling process;
· Submit an updated batch analysis for the drug product for the specific lot that will be used for manufacturing all future drug product;
· Provide additional details for the methodology for the Resorufin (CYP2B1) potency and the PrestoBlue cell metabolic assays;
· Provide a few examples of common microcatheters that fit the specifications in the Angiography Procedure Manual;
· Clarify the language in the Pharmacy Manual regarding proper use of the syringe fill with the drug product; and
· Provide a discussion with data for the potential for cellular and humoral immune reactivity against the heterologous rat CYP2B1 protein and potential for induction of autoimmune-mediated toxicities in the Company’s study population.
There has been no further communication with the FDA regarding the clinical hold
I feel like NO Company ever has been looking to take any stake in the SCAM known now as Pharmacyte. The end of this SCAM is near.
The 1st of a Thousand PR Pump Updates over a 5+ year period or until the money train runs out for Kenny and his band of thieves. Strange how KW needed to bury the FDA list at the end of the 10q but he will now issue a PR every time they fart.
The news is good. For anyone who sold out of this total SCAM.
LOL. The news is good? Not even a good try. Crabtree LMAO
Any Biotech that receives a list of deficiencies like this is on the FDA radar and my guess is the FDA will not waste any of their time conversing with PMCB. They can smell the stink of incompetence. Just the fact that this SCAM wasted the FDA's time reviewing PMCB's sham IND while so many other REAL Biotech's are waiting for reviews of important treatments is another example of these scumbag's willing to do anything to keep the money train rolling.